Phoenix Financial’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
NTCM
CI
BCM
Phoenix Financial's CLBT Position: Q1 2026 in Review
Phoenix Financial increased its Cellebrite (CLBT) stake by 67% in Q1 2026, buying an estimated $25.2M and bringing the position to 4,181,269 shares worth $57.6M. The position accounts for 0.55% of the portfolio, ranked #45.
Phoenix Financial first reported a position in CLBT in Q4 2021 and has held it in 18 quarters since. 221 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.
- Phoenix Financial held 4,181,269 shares of Cellebrite worth $57.6M as of Q1 2026.
- Phoenix Financial bought 1,670,495 Cellebrite shares in Q1 2026, an estimated $25.2M.
- Cellebrite made up 0.55% of Phoenix Financial's portfolio in Q1 2026, its #45 holding.
- Phoenix Financial first reported a position in Cellebrite in Q4 2021 and has held it in 18 quarters since.
- 221 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.
Based on Phoenix Financial's 13F filing for Q1 2026, filed 11 May 2026.